| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 765,401 | 648,459 | 612,136 | 994,559 | | Cost of Revenue | 278,471 | 217,456 | 224,452 | 355,341 | | | Gross Profit | 486,930 | 431,003 | 387,684 | 639,218 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 451,910 | 455,870 | 482,136 | 523,437 | | Non Recurring | 4,668 | (4,668) |
-
| (8,864) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,352 | (20,199) | (94,452) | 124,645 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 443 | 2,709 | 1,419 | | Earnings Before Interest And Taxes | 29,891 | (18,382) | (93,117) | 126,064 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 29,891 | (18,382) | (93,117) | 126,064 | | Income Tax Expense | (8,892) | 6,991 | (32,503) | 57,657 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 38,783 | (26,747) | (59,240) | 68,407 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 38,783 | (26,747) | (59,240) | 68,407 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $38,783 | ($26,747) | ($59,240) | $68,407 |
|
0.11% Nasdaq 0.00%
Income Statement
